ProQR Therapeutics (PRQR) Capital Leases (2013 - 2016)

ProQR Therapeutics has reported Capital Leases for 3 years, with the latest figure at $16441.8 in Q4 2015.

• Quarterly Capital Leases fell 61.31% year-over-year to $16441.8 in Q4 2015, while the trailing twelve-month figure through Dec 2015 was $16441.8 (down 61.31% YoY) and the FY2015 annual result came in at $16661.9, down 63.13% from the prior year.
• Capital Leases declined to $16441.8 in Q4 2015 per PRQR's latest filing, from $33895.0 in the prior quarter.
• Over five years, Capital Leases peaked at $65332.3 in Q4 2013 and troughed at $16441.8 in Q4 2015.
• A 3-year average of $42516.5 and a median of $42494.3 in 2014 frame the typical range for Capital Leases.
• The sharpest annual moves came in 2014 and 2015: Capital Leases sank 34.96% in 2014, then tumbled 61.31% in 2015.
• Over 3 years, Capital Leases stood at $65332.3 in 2013, then sank by 34.96% to $42494.3 in 2014, then sank by 61.31% to $16441.8 in 2015.
• According to Business Quant data, Capital Leases over the past three periods registered $16441.8, $33895.0, and $42494.3 for Q4 2015, Q1 2015, and Q4 2014 respectively.